Interestingly, we identified AFP as a potential biomarker specific to CCA tissues, with decreased expression observed at both the transcriptional (Figure 2(D-1)) and translational levels (Supplementary Figure S5A), as opposed to the well-documented trends observed in HCC. The gene discussed is AFP; the disease is cholangiocarcinoma.